Jiwanjeet Dhaliwall

McGill University — Canada

Medicine · Health Sciences

4h-index550citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(4), Viral gastroenteritis research and epidemiology(4), Transgenic Plants and Applications(4), COVID-19 Clinical Research Studies(1), Influenza Virus Research Studies(1)

Publications5 total

Marked Reduction in Viral Load and Symptoms in Breakthrough COVID-19 Cases Following AS03-Adjuvanted Plant-Made VLP Vaccination
SSRN Electronic Journal·2023Open Access
Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03
2022· 7 citedOpen Access
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Nature Medicine·2021· 301 citedOpen Access
Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants
2020· 59 citedOpen Access
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials
The Lancet·2020· 183 cited

Frequent Co-authors

Brian J. Ward(5), Annie Séguin(5), А. И. Макарков(5), Stéphane Pillet(5), Sonia Trépanier(5), Nathalie Landry(5), Philipe Gobeil(4), Judith Atkins(3), Iohann Boulay(3), Manon Couture(3), Marc‐André D’Aoust(3), Karen Hager(3), Asif Mahmood(3), Pierre-Yves Charbonneau(2), Carolyn Finkle(2), Matthew P. Cheng(2), Patricia Schimke(2), Sylvie St-Martin(2), Nathalie Charland(2), Emmy Pahmer(2)